In the example shown for BRD2, almost all hits correspond to negative selection screens performed in cancer cell lines, indicating that knock‐out of BRD2 is detrimental in many cancer cell lines and supporting the case for BRD2 as a candidate drug target.65–67 Users can interrogate each screen for experimental metadata and ranked hits lists with associated numeric scores. Here, BRD2 is linked to cancer.